kn73348l | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Suwanwongse%2C_Kulachanya%3B_Shabarek%2C_Nehad>
?:doi	10.1016/j.msard.2020.102201
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.msard.2020.102201>
?:journal	Mult_Scler_Relat_Disord
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/92eae87ff6d0d583de905c7d646124f229efe5c8.json
?:pmc_json_files	document_parses/pmc_json/PMC7227515.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7227515>
?:pmid	<https://research.tib.eu/covid-19/entity/32426210.0>
?:pmid	32426210.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/92eae87ff6d0d583de905c7d646124f229efe5c8>
?:source	Elsevier; Medline; PMC
?:title	Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-05-15

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/kn73348l>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/kn73348l>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all